A group of researchers from the Technion and the United States reports a breakthrough in MRI scanning in a paper published in Nature Communications.
Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
In partnership with Gemini Untwined, XRlabs’ Surgical Intelligence platform generated custom implants in seconds and enabled successful craniopagus twin separation
Now, a study published in Science Translational Medicine offers a new strategy capable of identifying chemical compounds that could be further developed into antibiotic therapies with high selectivity for N. gonorrhoeae.
A study led by Georgia Institute of Technology’s Associate Professor Costas Arvanitis takes a major step toward safer and more effective treatment and diagnosis of brain diseases. His team’s research, published in Advanced Science, shows how combining artificial intelligence (AI) with focused ultrasound can safely deliver therapies and improve diagnostic interventions to the brain.
The integration of AI into digital pathology has the potential to transform cancer diagnostics by enabling scalable, quantitative analysis of tissue specimens. However, widespread deployment of AI-assisted pathology remains challenged by the need for costly imaging infrastructure and the lack of reliable mechanisms to assess prediction confidence.
Experts in Heidelberg, Germany, have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections.
Subtle Medical has announced FDA clearance for SubtleHD(CT), an AI-powered image enhancement solution designed to reduce noise and improve low contrast detectability across CT imaging
Three commercially available radiology AI systems have shown the potential to flag early signs of breast cancer up to six years before a diagnosis, according to a study published in Radiology.
Mayo Clinic researchers and collaborators have shown that artificial intelligence (AI) can analyze routine pathology slides to help classify meningiomas, the most common primary brain tumor in adults, and predict a patient’s risk of tumor recurrence.